Hydroxypropyl-beta-cyclodextrin

SKU: orb1700381

Description

Hydroxypropyl-beta-cyclodextrin (HPbCD) is a cyclodextrin derivative investigated as a therapeutic candidate for Niemann-Pick disease type C, receiving initial regulatory approval in 2009. Its application extends to in vitro and in vivo research for solubilizing compounds and mobilizing cholesterol in cellular models.

Research Area

Infectious Disease & Virology

Key Properties

• CAS Number: 107745-73-3
• MW: 1541.547
• Formula: C₆₃H₁₁₂O₄₂
• SMILES: [H][C@@]12O[C@H](COCC(C)O)[C@@]([H])(O[C@@]3([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]4([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]5([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]6([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]7([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]8([H])O[C@H](COCC(C)O)[C@@]([H])(O1)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)C2O
• Target: SARS-CoV,Others

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

171360280